Apeloa Pharmaceutical Co.,Ltd

Symbol: 000739.SZ

SHZ

14.01

CNY

Market price today

  • 17.2151

    P/E Ratio

  • 0.3678

    PEG Ratio

  • 16.38B

    MRK Cap

  • 0.02%

    DIV Yield

Apeloa Pharmaceutical Co.,Ltd (000739-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.24%

Operating Profit Margin

0.10%

Net Profit Margin

0.09%

Return on Assets

0.08%

Return on Equity

0.17%

Return on Capital Employed

0.17%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO:Mr. Fangmeng Zhu
Full-time employees:6791
City:Dongyang
Address:No. 333, Jiangnan Road
IPO:1997-05-09
CIK:

Apeloa Pharmaceutical Co.,Ltd researches and develops, produces, and sells pharmaceutical products in China and internationally. It provides products in the cardio-cerebrovascular, anti-infection, anti-viral, anti-tumor, and other treatment areas. The company offers preparations, raw material intermediates, and veterinary drugs primarily under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. It also provides contract research and development, and production services for pharmaceutical companies. The company is headquartered in Dongyang, China.

General Outlook

When we look at how much money they make before expenses, they keep 0.242% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.099%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.092%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.079% return, is a testament to Apeloa Pharmaceutical Co.,Ltd's adeptness in optimizing resource deployment. Apeloa Pharmaceutical Co.,Ltd's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.173%. Furthermore, the proficiency of Apeloa Pharmaceutical Co.,Ltd in capital utilization is underscored by a remarkable 0.170% return on capital employed.

Stock Prices

Apeloa Pharmaceutical Co.,Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $12.91, while its low point bottomed out at $12.59. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Apeloa Pharmaceutical Co.,Ltd's stock market.

Liquidity Ratios

Analyzing 000739.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 133.65% gauges short-term asset coverage for liabilities. The quick ratio (104.33%) assesses immediate liquidity, while the cash ratio (54.85%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio133.65%
Quick Ratio104.33%
Cash Ratio54.85%

Profitability Ratios

000739.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 10.43% underscores its earnings before tax deductions. The effective tax rate stands at 12.42%, revealing its tax efficiency. The net income per EBT, 87.82%, and the EBT per EBIT, 105.82%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 9.86%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin10.43%
Effective Tax Rate12.42%
Net Income per EBT87.82%
EBT per EBIT105.82%
EBIT per Revenue9.86%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 1.34, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations. Meanwhile, a 1 cash conversion cycle and 343.04% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding104
Days of Inventory Outstanding78
Operating Cycle184.28
Days of Payables Outstanding199
Cash Conversion Cycle-15
Receivables Turnover3.43
Payables Turnover1.83
Inventory Turnover4.69
Fixed Asset Turnover3.24
Asset Turnover0.86

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.93, and free cash flow per share, 0.39, depict cash generation on a per-share basis. The cash per share value, 3.16, showcases liquidity position. A payout ratio of 0.36 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.93
Free Cash Flow per Share0.39
Cash per Share3.16
Payout Ratio0.36
Operating Cash Flow Sales Ratio0.09
Free Cash Flow to Operating Cash Flow Ratio0.42
Cash Flow Coverage Ratio1.12
Short Term Coverage Ratio1.15
Capital Expenditure Coverage Ratio1.72
Dividend Paid and Capex Coverage Ratio1.07
Dividend Payout Ratio0.02

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 7.18%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.15, we discern the balance between debt and equity financing. The long-term debt to capitalization, 0.38%, and total debt to capitalization, 13.01%, ratios shed light on its capital structure. An interest coverage of 33.44 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio7.18%
Debt Equity Ratio0.15
Long Term Debt to Capitalization0.38%
Total Debt to Capitalization13.01%
Interest Coverage33.44
Cash Flow to Debt Ratio1.12
Company Equity Multiplier2.08

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 9.76, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.90, reflects the portion of profit attributed to each share. The book value per share, 5.32, represents the net asset value distributed per share, while the tangible book value per share, 5.06, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share9.76
Net Income Per Share0.90
Book Value Per Share5.32
Tangible Book Value Per Share5.06
Shareholders Equity Per Share5.32
Interest Debt Per Share2.97
Capex Per Share-0.54

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 8.28%, indicates top-line expansion, while the gross profit growth, 8.36%, reveals profitability trends. EBIT growth, 6.97%, and operating income growth, 6.97%, offer insights into operational profitability progression. The net income growth, 6.69%, showcases bottom-line expansion, and the EPS growth, 5.88%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth8.28%
Gross Profit Growth8.36%
EBIT Growth6.97%
Operating Income Growth6.97%
Net Income Growth6.69%
EPS Growth5.88%
EPS Diluted Growth5.88%
Dividends per Share Growth5.57%
Operating Cash Flow Growth-22.23%
Free Cash Flow Growth-50.93%
10-Year Revenue Growth per Share99.55%
5-Year Revenue Growth per Share80.48%
3-Year Revenue Growth per Share46.05%
10-Year Operating CF Growth per Share269.09%
5-Year Operating CF Growth per Share24.83%
3-Year Operating CF Growth per Share-1.89%
10-Year Net Income Growth per Share329.77%
5-Year Net Income Growth per Share187.03%
3-Year Net Income Growth per Share30.23%
10-Year Shareholders Equity Growth per Share136.62%
5-Year Shareholders Equity Growth per Share87.53%
3-Year Shareholders Equity Growth per Share42.84%
10-Year Dividend per Share Growth per Share246.32%
5-Year Dividend per Share Growth per Share222.14%
3-Year Dividend per Share Growth per Share91.72%
Receivables Growth5.85%
Inventory Growth15.62%
Asset Growth6.25%
Book Value per Share Growth12.90%
Debt Growth309.25%
R&D Expense Growth1.44%
SGA Expenses Growth74.90%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 17,958,796,135.24, captures the company's total value, considering both debt and equity. Income quality, 0.98, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.01, gauges operational efficiency, while the research and development to revenue, 4.73%, highlights investment in innovation. The ratio of intangibles to total assets, 2.66%, indicates the value of non-physical assets, and capex to operating cash flow, -61.13%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value17,958,796,135.24
Income Quality0.98
Sales General and Administrative to Revenue0.01
Research and Development to Revenue4.73%
Intangibles to Total Assets2.66%
Capex to Operating Cash Flow-61.13%
Capex to Revenue-5.52%
Capex to Depreciation-112.79%
Graham Number10.40
Return on Tangible Assets8.49%
Graham Net Net-0.06
Working Capital2,060,432,560
Tangible Asset Value5,920,931,251
Net Current Asset Value1,861,533,505
Invested Capital1
Average Receivables2,353,656,474.5
Average Payables3,162,231,013
Average Inventory1,942,544,480.5
Days Sales Outstanding77
Days Payables Outstanding85
Days of Inventory On Hand88
ROIC9.82%
ROE0.17%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 2.82, and the price to book ratio, 2.82, reflect the market's valuation relative to the company's book value. The price to sales ratio, 1.58, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 40.18, and price to operating cash flows, 16.76, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio2.82
Price to Book Ratio2.82
Price to Sales Ratio1.58
Price Cash Flow Ratio16.76
Price Earnings to Growth Ratio0.37
Enterprise Value Multiple15.22
Price Fair Value2.82
Price to Operating Cash Flow Ratio16.76
Price to Free Cash Flows Ratio40.18
Price to Tangible Book Ratio2.91
Enterprise Value to Sales1.57
Enterprise Value Over EBITDA10.94
EV to Operating Cash Flow17.41
Earnings Yield5.83%
Free Cash Flow Yield2.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Apeloa Pharmaceutical Co.,Ltd (000739.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 17.215 in 2024.

What is the ticker symbol of Apeloa Pharmaceutical Co.,Ltd stock?

The ticker symbol of Apeloa Pharmaceutical Co.,Ltd stock is 000739.SZ.

What is company IPO date?

IPO date of Apeloa Pharmaceutical Co.,Ltd is 1997-05-09.

What is company current share price?

Current share price is 14.010 CNY.

What is stock market cap today?

The market cap of stock today is 16382174377.000.

What is PEG ratio in 2024?

The current 0.368 is 0.368 in 2024.

What is the number of employees in 2024?

In 2024 the company has 6791.